##gff-version 3
##sequence-region O43918 1 545
O43918	UniProtKB	Chain	1	545	.	.	.	ID=PRO_0000064513;Note=Autoimmune regulator	
O43918	UniProtKB	Domain	1	105	.	.	.	Note=HSR;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00747	
O43918	UniProtKB	Domain	181	280	.	.	.	Note=SAND;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00185	
O43918	UniProtKB	Zinc finger	296	343	.	.	.	Note=PHD-type 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00146	
O43918	UniProtKB	Zinc finger	434	475	.	.	.	Note=PHD-type 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00146	
O43918	UniProtKB	Region	295	298	.	.	.	Note=Interaction with histone H3 not methylated at 'Lys-4'	
O43918	UniProtKB	Region	304	312	.	.	.	Note=Interaction with histone H3 not methylated at 'Lys-4'	
O43918	UniProtKB	Region	331	335	.	.	.	Note=Interaction with histone H3 not methylated at 'Lys-4'	
O43918	UniProtKB	Motif	7	11	.	.	.	Note=LXXLL motif 1	
O43918	UniProtKB	Motif	63	67	.	.	.	Note=LXXLL motif 2	
O43918	UniProtKB	Motif	414	418	.	.	.	Note=LXXLL motif 3	
O43918	UniProtKB	Motif	516	520	.	.	.	Note=LXXLL motif 4	
O43918	UniProtKB	Alternative sequence	1	292	.	.	.	ID=VSP_004089;Note=In isoform 2%2C isoform 3 and isoform 4. MATDAALRRLLRLHRTEIAVAVDSAFPLLHALADHDVVPEDKFQETLHLKEKEGCPQAFHALLSWLLTQDSTAILDFWRVLFKDYNLERYGRLQPILDSFPKDVDLSQPRKGRKPPAVPKALVPPPRLPTKRKASEEARAAAPAALTPRGTASPGSQLKAKPPKKPESSAEQQRLPLGNGIQTMSASVQRAVAMSSGDVPGARGAVEGILIQQVFESGGSKKCIQVGGEFYTPSKFEDSGSGKNKARSSSGPKPLVRAKGAQGAAPGGGEARLGQQGSVPAPLALPSDPQLH->MWLVYSSGAPGTQQPARNRVFFPIGMAPGGVCWRPDGWGTGGQGRISGPGSMGAGQRLGSSGTQRCCWGSCFGKEVALRRVLHPS;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15489334,ECO:0000303|PubMed:9398839;Dbxref=PMID:15489334,PMID:9398839	
O43918	UniProtKB	Alternative sequence	293	293	.	.	.	ID=VSP_043529;Note=In isoform 4. Q->PVCMGVSCLCQ;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O43918	UniProtKB	Alternative sequence	377	545	.	.	.	ID=VSP_004090;Note=In isoform 3. VRGPPGEPLAGMDTTLVYKHLPAPPSAAPLPGLDSSALHPLLCVGPEGQQNLAPGARCGVCGDGTDVLRCTHCAAAFHWRCHFPAGTSRPGTGLRCRSCSGDVTPAPVEGVLAPSPARLAPGPAKDDTASHEPALHRDDLESLLSEHTFDGILQWAIQSMARPAAPFPS->PRCQGWTPRPCTPYCVWVLRVSRTWLLVRVAGCAEMVRTCCGVLTAPLPSTGAATSQPAPPGPGRACAADPAQET;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9398839;Dbxref=PMID:9398839	
O43918	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_026480;Note=In APS1. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12625412;Dbxref=dbSNP:rs179363875,PMID:12625412	
O43918	UniProtKB	Natural variant	15	15	.	.	.	ID=VAR_013713;Note=In APS1%3B prevents homooligomerization%3B slightly alters subcellular localization%3B no effect on the transcriptional transactivation activity. R->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:15712268;Dbxref=dbSNP:rs179363876,PMID:11524731,PMID:14974083,PMID:15712268	
O43918	UniProtKB	Natural variant	16	16	.	.	.	ID=VAR_013714;Note=In APS1%3B prevents homooligomerization%3B slightly alters subcellular localization%3B no effect on the transcriptional transactivation activity. T->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:11524733,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:15712268;Dbxref=dbSNP:rs179363877,PMID:11524731,PMID:11524733,PMID:14974083,PMID:15712268	
O43918	UniProtKB	Natural variant	21	21	.	.	.	ID=VAR_026481;Note=In APS1%3B no effect on homooligomerization%3B no effect on subcellular localization%3B no effect on the transcriptional transactivation activity. A->V;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12050215,ECO:0000269|PubMed:14974083;Dbxref=dbSNP:rs179363886,PMID:12050215,PMID:14974083	
O43918	UniProtKB	Natural variant	22	23	.	.	.	ID=VAR_026482;Note=In APS1%3B prevents homodimerization. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15712268;Dbxref=PMID:15712268	
O43918	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_005004;Note=In APS1%3B abolishes association with cytoplasmic tubular structures and homodimerization%3B loss of doted nuclear localization%3B nuclear smear. L->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11274163,ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:26084028,ECO:0000269|PubMed:9888391;Dbxref=dbSNP:rs179363878,PMID:11274163,PMID:11524731,PMID:14974083,PMID:26084028,PMID:9888391	
O43918	UniProtKB	Natural variant	29	29	.	.	.	ID=VAR_013715;Note=In APS1. L->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12173302,ECO:0000269|PubMed:14974083;Dbxref=dbSNP:rs179363879,PMID:12173302,PMID:14974083	
O43918	UniProtKB	Natural variant	77	77	.	.	.	ID=VAR_026483;Note=In APS1%3B loss of homooligomerization. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15712268;Dbxref=dbSNP:rs179363887,PMID:15712268	
O43918	UniProtKB	Natural variant	78	78	.	.	.	ID=VAR_013716;Note=In APS1%3B loss of homooligomerization. W->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:11524733,ECO:0000269|PubMed:11836330,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:15712268;Dbxref=dbSNP:rs179363880,PMID:11524731,PMID:11524733,PMID:11836330,PMID:14974083,PMID:15712268	
O43918	UniProtKB	Natural variant	80	80	.	.	.	ID=VAR_013717;Note=In APS1. V->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10677297,ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:14974083;Dbxref=dbSNP:rs179363881,PMID:10677297,PMID:11524731,PMID:14974083	
O43918	UniProtKB	Natural variant	83	83	.	.	.	ID=VAR_005005;Note=In APS1. K->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:9398839;Dbxref=dbSNP:rs121434255,PMID:11524731,PMID:14974083,PMID:9398839	
O43918	UniProtKB	Natural variant	85	85	.	.	.	ID=VAR_013718;Note=In APS1. Y->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10677297,ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:12050215;Dbxref=dbSNP:rs179363882,PMID:10677297,PMID:11524731,PMID:12050215	
O43918	UniProtKB	Natural variant	90	90	.	.	.	ID=VAR_013719;Note=In APS1%3B decreases doted nuclear localization. Y->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs179363883,PMID:11524731,PMID:14974083,PMID:26084028	
O43918	UniProtKB	Natural variant	93	93	.	.	.	ID=VAR_013720;Note=In APS1. L->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:14974083;Dbxref=dbSNP:rs179363884,PMID:11524731,PMID:14974083	
O43918	UniProtKB	Natural variant	228	228	.	.	.	ID=VAR_014422;Note=In APS1%3B changes the subcellular localization and in addition disrupts the transactivating capacity of the wild-type AIRE%3B acts with a dominant negative effect by binding to the wild-type AIRE thus preventing the protein from forming the complexes needed for transactivation. G->W;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11600535,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:16114041;Dbxref=dbSNP:rs121434257,PMID:11600535,PMID:14974083,PMID:16114041	
O43918	UniProtKB	Natural variant	252	252	.	.	.	ID=VAR_026484;Note=In APS1. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11836330;Dbxref=dbSNP:rs34397615,PMID:11836330	
O43918	UniProtKB	Natural variant	278	278	.	.	.	ID=VAR_005006;Note=S->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:12625412,ECO:0000269|PubMed:9717837;Dbxref=dbSNP:rs1800520,PMID:11524731,PMID:12625412,PMID:9717837	
O43918	UniProtKB	Natural variant	298	298	.	.	.	ID=VAR_076940;Note=Unknown pathological significance. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs763636007,PMID:26084028	
O43918	UniProtKB	Natural variant	299	299	.	.	.	ID=VAR_076941;Note=Unknown pathological significance. C->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs751066946,PMID:26084028	
O43918	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_013721;Note=In APS1%3B no effect on protein structure or on interaction with histone H3%3B no effect on doted nuclear localization%3B dominant-negatif effect on regulation of target gene transcription. V->M;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:15649886,ECO:0000269|PubMed:18292755,ECO:0000269|PubMed:19446523,ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs150634562,PMID:11524731,PMID:15649886,PMID:18292755,PMID:19446523,PMID:26084028	
O43918	UniProtKB	Natural variant	302	302	.	.	.	ID=VAR_076942;Note=Found in patients with hypothyroidism and organ- and cytokine-specific autoantibodies%3B no effect on doted nuclear localization%3B dominant-negatif effect on regulation of target gene transcription. C->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=PMID:26084028	
O43918	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_076943;Note=Unknown pathological significance. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs139808903,PMID:26084028	
O43918	UniProtKB	Natural variant	303	303	.	.	.	ID=VAR_076944;Note=Unknown pathological significance. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs778929451,PMID:26084028	
O43918	UniProtKB	Natural variant	305	305	.	.	.	ID=VAR_013722;Note=Found in a patient with pernicious anemia and neuropathy%3B unknown pathological significance%3B no effect on doted nuclear localization%3B dominant-negatif effect on regulation of target gene transcription. G->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=PMID:26084028	
O43918	UniProtKB	Natural variant	306	306	.	.	.	ID=VAR_076945;Note=Unknown pathological significance. G->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs754932526,PMID:26084028	
O43918	UniProtKB	Natural variant	309	309	.	.	.	ID=VAR_076946;Note=Unknown pathological significance. I->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs74162062,PMID:26084028	
O43918	UniProtKB	Natural variant	311	311	.	.	.	ID=VAR_013723;Note=In APS1%3B impairs zinc binding and folding of the PHD-type 1 zinc finger%3B dominant-negatif effect on the regulation of target gene transcription%3B no effect on doted nuclear localization%3B dominant-negatif effect on regulation of target gene transcription. C->Y;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10677297,ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:12050215,ECO:0000269|PubMed:15649886,ECO:0000269|PubMed:18292755,ECO:0000269|PubMed:19446523,ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs386833674,PMID:10677297,PMID:11524731,PMID:12050215,PMID:15649886,PMID:18292755,PMID:19446523,PMID:26084028	
O43918	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_076947;Note=Unknown pathological significance. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs202027254,PMID:26084028	
O43918	UniProtKB	Natural variant	316	316	.	.	.	ID=VAR_076948;Note=Unknown pathological significance%3B found in a patient with pernicious anemia. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs139874934,PMID:26084028	
O43918	UniProtKB	Natural variant	319	319	.	.	.	ID=VAR_076949;Note=Unknown pathological significance. H->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs776951380,PMID:26084028	
O43918	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_026485;Note=In APS1%3B no significant effect on structure%2C but may alter protein interactions%3B no effect on doted nuclear localization%3B dominant-negatif effect on regulation of target gene transcription. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11275943,ECO:0000269|PubMed:19446523,ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs179363885,PMID:11275943,PMID:19446523,PMID:26084028	
O43918	UniProtKB	Natural variant	326	326	.	.	.	ID=VAR_013724;Note=In APS1%3B alters folding of the PHD-type 1 zinc finger. P->Q;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10677297,ECO:0000269|PubMed:11524731,ECO:0000269|PubMed:14974083,ECO:0000269|PubMed:15649886,ECO:0000269|PubMed:19446523;Dbxref=dbSNP:rs179363885,PMID:10677297,PMID:11524731,PMID:14974083,PMID:15649886,PMID:19446523	
O43918	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_076950;Note=Found in a patient with acrofacial vitiligo and gastric parietal cell autoantibodies%3B no effect on doted nuclear localization%3B dominant-negatif effect on regulation of target gene transcription. R->Q;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs775921321,PMID:26084028	
O43918	UniProtKB	Natural variant	328	328	.	.	.	ID=VAR_076951;Note=Unknown pathological significance. R->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs74162063,PMID:26084028	
O43918	UniProtKB	Natural variant	332	332	.	.	.	ID=VAR_076952;Note=Unknown pathological significance. S->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs766901260,PMID:26084028	
O43918	UniProtKB	Natural variant	484	484	.	.	.	ID=VAR_076953;Note=Found in a patient with acrofacial vitiligo and gastric parietal cell autoantibodies%3B unknown pathological significance. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=dbSNP:rs769470638,PMID:26084028	
O43918	UniProtKB	Natural variant	539	539	.	.	.	ID=VAR_026486;Note=In APS1. P->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11836330;Dbxref=dbSNP:rs179363889,PMID:11836330	
O43918	UniProtKB	Mutagenesis	28	29	.	.	.	Note=Loss of doted nuclear location%2C forms nuclear smears. Loss of transactivation activity on target genes transcription. LL->PP;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=PMID:26084028	
O43918	UniProtKB	Mutagenesis	97	97	.	.	.	Note=Loss of transactivation activity on target gene transcription%3B no dominant-negatif effect on target gene transcription. Loss of doted nuclear localization. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=PMID:26084028	
O43918	UniProtKB	Mutagenesis	295	295	.	.	.	Note=Abolishes interaction with histone H3. N->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19293276;Dbxref=PMID:19293276	
O43918	UniProtKB	Mutagenesis	297	297	.	.	.	Note=Strongly reduces interaction with unmethylated histone H3 and abolishes interaction with histone H3 trimethylated at 'Lys-4'. No effect on doted nuclear localization. Dominant-negatif effect on target gene transcription. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18292755,ECO:0000269|PubMed:26084028;Dbxref=PMID:18292755,PMID:26084028	
O43918	UniProtKB	Mutagenesis	298	298	.	.	.	Note=Reduces interaction with histone H3. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19293276;Dbxref=PMID:19293276	
O43918	UniProtKB	Mutagenesis	302	302	.	.	.	Note=Reduces transcriptional activation. C->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11274163;Dbxref=PMID:11274163	
O43918	UniProtKB	Mutagenesis	303	303	.	.	.	Note=Alters protein folding and abolishes interaction with histone H3. No effect on doted nuclear localization. Dominant-negatif effect on target gene transcription. R->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:19293276,ECO:0000269|PubMed:26084028;Dbxref=PMID:19293276,PMID:26084028	
O43918	UniProtKB	Mutagenesis	304	304	.	.	.	Note=Strongly reduces interaction with histone H3. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19293276;Dbxref=PMID:19293276	
O43918	UniProtKB	Mutagenesis	307	307	.	.	.	Note=Reduces interaction with histone H3. E->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:19293276;Dbxref=PMID:19293276	
O43918	UniProtKB	Mutagenesis	312	312	.	.	.	Note=Abolishes interaction with histone H3. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18292755;Dbxref=PMID:18292755	
O43918	UniProtKB	Mutagenesis	312	312	.	.	.	Note=No effect on doted nuclear localization. Dominant-negatif effect on target gene transcription. D->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=PMID:26084028	
O43918	UniProtKB	Mutagenesis	437	437	.	.	.	Note=Reduces transcription activation. C->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11274163;Dbxref=PMID:11274163	
O43918	UniProtKB	Mutagenesis	446	446	.	.	.	Note=Dominant-negatif effect on regulation of target gene transcription. C->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=PMID:26084028	
O43918	UniProtKB	Mutagenesis	471	471	.	.	.	Note=No effect on regulation of target gene transcription. R->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:26084028;Dbxref=PMID:26084028	
O43918	UniProtKB	Sequence conflict	437	467	.	.	.	Note=CGDGTDVLRCTHCAAAFHWRCHFPAGTSRPG->W;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O43918	UniProtKB	Beta strand	298	303	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XWH	
O43918	UniProtKB	Beta strand	306	310	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KE1	
O43918	UniProtKB	Beta strand	312	314	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KE1	
O43918	UniProtKB	Beta strand	317	319	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2KE1	
O43918	UniProtKB	Turn	320	322	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XWH	
O43918	UniProtKB	Beta strand	323	325	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XWH	
O43918	UniProtKB	Helix	338	342	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1XWH	
O43918	UniProtKB	Turn	423	426	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LRI	
O43918	UniProtKB	Turn	435	437	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LRI	
O43918	UniProtKB	Beta strand	447	449	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LRI	
O43918	UniProtKB	Helix	455	458	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LRI	
O43918	UniProtKB	Turn	460	462	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LRI	
O43918	UniProtKB	Beta strand	467	469	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LRI	
O43918	UniProtKB	Turn	473	476	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:2LRI	
